Transformers: connection, capabilities and culture in modern pharma

  Dan Masquelier, Partner, Cormis Partnership, talks about the importance of connection, capabilities and culture in a modern pharma ecosystem.   What is Cormis...

Andrew Waiton explains why good habits start from the inside

KIE to success   Key Opinion Leaders, Thought Leaders and Key External Experts (KEE) have – for years – led best practice and influenced...

Training your Millennials: How to measure the training investment in your Generation Y employees.

Historically, the paradigm has been that, ‘of course’ organisations should provide training for their employees. It engenders loyalty, and it is the socially responsible...

Latest articles

Ipad and the cloud: NHSX

NHSX: Combining the best talent from government, the NHS and industry.

A new joint unit, NHSX, will be created to bring the benefits of modern technology to every patient and clinician. It will combine the...
Dr Allan Jordan and Ms Louisa Jordison have joined Sygnature Discovery.

Sygnature Discovery makes key appointments

Sygnature Discovery has made two key appointments, Dr Allan Jordan and Ms Louisa Jordison. Ms Jordison joins the independent integrated drug discovery and pre-clinical services...
results published for KEYTRUDA for advanced renal cell carcinoma

KEYTRUDA results published for advanced renal cell carcinoma

MSD has announced presentation of the full results from the pivotal Phase 3 KEYNOTE-426 trial investigating KEYTRUDA, MSD’s anti-PD-1 therapy, in combination with Inlyta...